SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-171623
Filing Date
2021-05-25
Accepted
2021-05-25 06:06:31
Documents
13
Period of Report
2021-05-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d153193d8k.htm   iXBRL 8-K 42331
2 EX-99.1 d153193dex991.htm EX-99.1 13934
  Complete submission text file 0001193125-21-171623.txt   184470

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mnkd-20210520.xsd EX-101.SCH 3094
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnkd-20210520_lab.xml EX-101.LAB 18139
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnkd-20210520_pre.xml EX-101.PRE 11424
6 EXTRACTED XBRL INSTANCE DOCUMENT d153193d8k_htm.xml XML 3382
Mailing Address 30930 RUSSELL RANCH ROAD SUITE 300 WESTLAKE VILLAGE CA 91362
Business Address 30930 RUSSELL RANCH ROAD SUITE 300 WESTLAKE VILLAGE CA 91362 818-661-5000
MANNKIND CORP (Filer) CIK: 0000899460 (see all company filings)

IRS No.: 133607736 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50865 | Film No.: 21957281
SIC: 2834 Pharmaceutical Preparations